BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ing Lorenzini K, Girardin F. Direct‐acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV‐infected patients. Liver Int 2019;40:32-44. [DOI: 10.1111/liv.14283] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Yang X, Tang Y, Xu D, Zhang G, Xu P, Tang H, Pang L. Efficacy and safety of ledipasvir/sofosbuvir for hepatitis C among drug users: a systematic review and meta-analysis. Virol J 2021;18:156. [PMID: 34315488 DOI: 10.1186/s12985-021-01625-w] [Reference Citation Analysis]
2 Girardin F, Tuch A, Eddowes L, Preisig M, Negro F. Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: a cost-effectiveness analysis. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100464] [Reference Citation Analysis]
3 Karbownik A, Szkutnik-Fiedler D, Grabowski T, Wolc A, Stanisławiak-Rudowicz J, Jaźwiec R, Grześkowiak E, Szałek E. Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats. Pharmaceutics 2021;13:2172. [PMID: 34959453 DOI: 10.3390/pharmaceutics13122172] [Reference Citation Analysis]
4 Hintz A, Umland T, Niess G, Guendogdu M, Moerner A, Tacke F. Pharmacotherapy Profiles in People with Opioid Use Disorders: Considerations for Relevant Drug-Drug Interactions with Antiviral Treatments for Hepatitis C. Pathogens 2021;10:648. [PMID: 34073674 DOI: 10.3390/pathogens10060648] [Reference Citation Analysis]
5 Marinangeli F, Giarratano A, Petrini F. Chronic pain and COVID-19: pathophysiological, clinical and organizational issues. Minerva Anestesiol 2021;87:828-32. [PMID: 33319953 DOI: 10.23736/S0375-9393.20.15029-6] [Reference Citation Analysis]
6 Durand M, Nagot N, Nhu QBT, Vallo R, Thuy LLT, Duong HT, Thanh BN, Rapoud D, Quillet C, Tran HT, Michel L, Tuyet TNT, Hai OKT, Hai VV, Feelemyer J, Perre PV, Jarlais DD, Minh KP, Laureillard D, Molès JP. Mitochondrial Genotoxicity of Hepatitis C Treatment among People Who Inject Drugs. J Clin Med 2021;10:4824. [PMID: 34768343 DOI: 10.3390/jcm10214824] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Blackard JT, Sherman KE. Drugs of Abuse and Their Impact on Viral Pathogenesis. Viruses 2021;13:2387. [PMID: 34960656 DOI: 10.3390/v13122387] [Reference Citation Analysis]
8 Turcu-Stiolica A, Doica IP, Ungureanu BS, Rogoveanu I, Florescu DN, Subtirelu MS, Gheonea DI. Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C. Pharmaceutics 2021;13:1683. [PMID: 34683976 DOI: 10.3390/pharmaceutics13101683] [Reference Citation Analysis]
9 Girardin F, Painter C, Hearmon N, Eddowes L, Kaiser S, Negro F, Vernaz N. Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy. JHEP Rep 2021;3:100279. [PMID: 34522875 DOI: 10.1016/j.jhepr.2021.100279] [Reference Citation Analysis]
10 Lyu H, Tang H, Liang Y, Huang S, Wang Y, Huang W, Zhou Y. Alcohol Consumption and Risk of Liver Fibrosis in People Living With HIV: A Systematic Review and Meta-Analysis. Front Immunol 2022;13:841314. [DOI: 10.3389/fimmu.2022.841314] [Reference Citation Analysis]
11 Liu CH, Chen CY, Su WW, Tseng KC, Lo CC, Liu CJ, Chen JJ, Peng CY, Shih YL, Yang SS, Huang CS, Huang KJ, Chang CY, Tsai MC, Kao WY, Fang YJ, Chen PY, Su PY, Tseng CW, Huang JJ, Lee PL, Lai HC, Hsieh TY, Chang CH, Huang YJ, Lee FJ, Chang CC, Kao JH. Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment. Gut 2022;71:176-84. [PMID: 33408122 DOI: 10.1136/gutjnl-2020-323569] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
12 Burton HJ, Khatiwada A, Chung D, Meissner EG. Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical Center. South Med J 2022;115:352-7. [PMID: 35649518 DOI: 10.14423/SMJ.0000000000001402] [Reference Citation Analysis]